Hypertension is the most common and significant risk factor for diseases of the heart, kidneys, and brain, yet in the United States, it continues to be an uphill battle getting patients to goal.

Loren Bonner

In the aftermath of the COVID-19 global pandemic, many important lessons have emerged. Among these lessons are legal rulings related to pharmacist rights and responsibilities.

David B. Brushwood, BSPharm, JD

In 2023, ISMP launched the first iteration of the ISMP Targeted Medication Safety Best Practices. The purpose of the best practices is to identify, inspire, and mobilize widespread, national adoption of consensus-based best practices to address recurring problems that continue to cause fatal and harmful errors despite repeated warnings in ISMP publications.

Institute for Safe Medication Practices, Horsham, PA

Pharmacists could comfortably and accurately perform high-quality rapid testing for respiratory illness and, at the same time, provide quick and effective treatment options for patients, according to a study conducted by the APhA Foundation and published August 2025 in Innovations in Pharmacy.

Elizabeth Briand

A pharmacist-led education intervention eased allergic rhinitis symptoms when compared with standard care over 180 days, a recent study revealed.

Jen Hand

A network developed solely for rural community pharmacies has paired with schools of pharmacy to address questions related to pharmacy practice and medication use.

Jen Hand

On August 7, 2025, FDA issued a statement expressing concerns with the safety and effectiveness of unapproved, animal-derived thyroid medications.

Lauren Howell, PharmD

Updates from FDA

APhA Staff

Almost all women experience uncomfortable mild symptoms before the onset of menses.

Mary Warner

Berberine supplements are making waves as an appetite suppressant and metabolic support.

Mickie Cathers

FDA intends to add new warnings to all opioid pain medications to emphasize the risks of long-term use, including a summary of study results showing the potential for addiction, misuse, and overdose during long-term use; stronger warnings about higher doses; and more.

Loren Bonner

During ACIP’s September 2025 meeting, members voted not to support a universal COVID-19 vaccine recommendation going forward.

Loren Bonner

It is widely known that aldosterone dysregulation plays a significant role in hard-to-control hypertension.

APhA Staff

More than one out of every 10 Americans has diabetes, according to CDC.

Elizabeth Briand

Patients with gout who were given NSAIDs to prevent flare-ups when starting allopurinol faced a higher risk of serious heart problems than those given colchicine or no preventive medication, said a study in Arthritis & Rheumatology from May 26, 2025.

Aiya Almogaber, PharmD

A major update to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines includes a more personalized approach to inhaled therapy in patients with stable COPD.

Aiya Almogaber, PharmD

How should clinicians safely discontinue benzodiazepine medications when continued use presents greater risks than benefits?

Jen Hand

A meta-analysis of mostly short-term studies published in the June 2025 issue of found no increased mortality with haloperidol use, nor that the drug was arrhythmogenic, despite decades of warnings about it causing QT prolongation (QTP).

Kevin Willmann

Artificial intelligence (AI) is rapidly transforming pharmacy practice, offering tools that can enhance medication safety. However, as AI becomes more embedded in prescribing, dispensing, and monitoring, it also introduces new risks.

Charlene Hope, PharmD, MS, CPPS, CPHQ, CPHFH

APhA Member News

APhA staff

Take the Crossword Challenge